Abstract
Pertussis is a vaccine preventable disease since late 1940s. However, it is still endemic in all countries and occurs in epidemic cycles. The number of cases/deaths has decreased during the last decade but a high number of deaths persists in Low and Medium Income Countries (LMIC). The epidemiological situation in LMIC is not precisely known due to lack of surveillance and specific diagnostic tools. A pragmatic approach in these countries should be to establish; (i) a hospital-based surveillance in the largest cities of the country with clinicians and nurses trained to detect clinical symptoms, to obtain biological samples for specific analysis and diagnosis; (ii) a reference laboratory as part of an international network of reference laboratories, under quality assurance, and able to perform at least PCR diagnosis and if possible detection of antibiotic resistance. This surveillance network would allow specific diagnosis of pertussis and facilitate the reporting of cases at national level, thereby improving awareness of the disease at clinician, population and decision maker levels. This network could allow a better evaluation of vaccine coverage, timely vaccination and impacts of modification of national vaccine strategy or type of pertussis vaccine used. Collaboration between this network and basic scientists should be strengthened through translational research projects in order to improve fundamental knowledge on pertussis in LMIC and help clinicians’ access to specific diagnostic tools.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aslanabadi A, Ghabili K, Shad K, Khalili M, Sajadi MM (2015) Emergence of whooping cough: notes from three early epidemics in Persia. Lancet Infect Dis 15(12):1480–1484. https://doi.org/10.1016/S1473-3099(15)00292-3
Barger-Kamate B, Deloria Knoll M, Kagucia EW, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SR, Levine OS, Madhi SA, Scott JA, Thea DM, Amornintapichet T, Anderson TP, Awori JO, Baillie VL, Chipeta J, DeLuca AN, Driscoll AJ, Goswami D, Higdon MM, Hossain L, Karron RA, Maloney S, Moore DP, Morpeth SC, Mwananyanda L, Ofordile O, Olutunde E, Park DE, Sow SO, Tapia MD, Murdoch DR, O’Brien KL, Kotloff KL, Pneumonia Etiology Research for Child Health Study G (2016) Pertussis-associated pneumonia in infants and children from low- and middle-income countries participating in the PERCH Study. Clin Infect Dis 63(suppl 4):S187–S196. https://doi.org/10.1093/cid/ciw546
Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J, Guiso N (1998) Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 17(5):412–418
Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He QS, van der Heide HGJ, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan RT, Lutynska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RSW, Xu YH, Yao SM, Zhang SM, Parkhill J, Mooi FR (2014) Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 5(2):e01074-14. https://doi.org/10.1128/mBio.01074-14
Bass JW, Stephenson SR (1987) The return of pertussis. Pediatr Infect Dis J 6(2):141–144
Ben Fraj I, Kechrid A, Guillot S, Bouchez V, Brisse S, Guiso N, Smaoui H (2018) Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016. J Med Microbiol. https://doi.org/10.1099/jmm.0.000892
Ben Fraj I, Smaoui H, Zghal M, Sassi O, Guiso N, Kechrid A (2019) Seroprevalence of pertussis among healthcare workers: a cross-sectional study from Tunisia. Vaccine 37(1):109–112. https://doi.org/10.1016/j.vaccine.2018.11.023
Bouchez V, Guiso N (2013) Bordetella holmesii: comparison of two isolates from blood and a respiratory sample. Adv Infect Dis 3:123–133. https://doi.org/10.4236/aid.2013.32020
Bouchez V, Guiso N (2015) Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. Pathog Dis 73(7):ftv055. https://doi.org/10.1093/femspd/ftv055
Breakwell L, Kelso P, Finley C, Schoenfeld S, Goode B, Misegades LK, Martin SW, Acosta AM (2016) Pertussis vaccine effectiveness in the setting of Pertactin-deficient pertussis. Pediatrics 137(5):e20153973. https://doi.org/10.1542/peds.2015-3973
Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P (2010) Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci 277(1698):3239–3245. https://doi.org/10.1098/rspb.2010.0994
Chen ZY, Zhang J, Cao LN, Zhang N, Zhu JP, Ping GL, Zhao JH, Li SM, He QS (2016) Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years. J Infect 73(1):38–44. https://doi.org/10.1016/j.jinf.2016.04.004
Cherry JD (2016) Pertussis in young infants throughout the world. Clin Infect Dis 63(suppl 4):S119–S122. https://doi.org/10.1093/cid/ciw550
Cherry JD, Tan T, Wirsing von Konig CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S (2012) Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis 54(12):1756–1764. https://doi.org/10.1093/cid/cis302
Dellepiane N, Pagliusi S, Registration Experts Working G (2018) Challenges for the registration of vaccines in emerging countries: differences in dossier requirements, application and evaluation processes. Vaccine 36(24):3389–3396. https://doi.org/10.1016/j.vaccine.2018.03.049
Fine PE, Clarkson JA (1982) The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1(8273):666–669
Forsyth KD, Tan T, von Konig CW, Heininger U, Chitkara AJ, Plotkin S (2018) Recommendations to control pertussis prioritized relative to economies: a global pertussis initiative update. Vaccine 36(48):7270–7275. https://doi.org/10.1016/j.vaccine.2018.10.028
Gross R, Keidel K, Schmitt K (2010) Resemblance and divergence: the “new” members of the genus Bordetella. Med Microbiol Immunol 199(3):155–163. https://doi.org/10.1007/s00430-010-0148-z
Guiso N, Hegerle N (2014) Other Bordetellas, lessons for and from pertussis vaccines. Expert Rev Vaccines 13(9):1125–1133. https://doi.org/10.1586/14760584.2014.942221
Guiso N, Wirsing von Konig CH (2016) Surveillance of pertussis: methods and implementation. Expert Rev Anti-Infect Ther 14(7):657–667. https://doi.org/10.1080/14787210.2016.1190272
Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von Konig CH, group EUP (2011) What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30(3):307–312. https://doi.org/10.1007/s10096-010-1104-y
Halperin SA, Langley JM, Ye L, MacKinnon-Cameron D, Elsherif M, Allen VM, Smith B, Halperin BA, McNeil SA, Vanderkooi OG, Dwinnell S, Wilson RD, Tapiero B, Boucher M, Le Saux N, Gruslin A, Vaudry W, Chandra S, Dobson S, Money D (2018) A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis 67(7):1063–1071. https://doi.org/10.1093/cid/ciy244
Hegerle N, Guiso N (2014) Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 13(9):1135–1146. https://doi.org/10.1586/14760584.2014.932254
Huang WT, Lin HC, Yang CH (2017) Undervaccination with diphtheria, tetanus, and pertussis vaccine: national trends and association with pertussis risk in young children. Hum Vaccin Immunother 13(4):757–761. https://doi.org/10.1080/21645515.2016.1249552
Kampmann B, Mackenzie G (2016) Morbidity and mortality due to Bordetella pertussis: a significant pathogen in West Africa? Clin Infect Dis 63:S142–S147. https://doi.org/10.1093/cid/ciw560
Kurova N, Timofeeva EV, Guiso N, Macina D (2018) A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia. Vaccine 36(52):7936–7942. https://doi.org/10.1016/j.vaccine.2018.11.007
Linz B, Ivanov YV, Preston A, Brinkac L, Parkhill J, Kim M, Harris SR, Goodfield LL, Fry NK, Gorringe AR, Nicholson TL, Register KB, Losada L, Harvill ET (2016) Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species. BMC Genomics 17(1):767. https://doi.org/10.1186/s12864-016-3112-5
Moriuchi K et al (2017) Molecular epidemiology of Bordetella pertussis in Cambodia determined by direct genotyping of clinical specimens. Int J Infect Dis 62:56–58. https://doi.org/10.1016/j.ijid.2017.07.015
Muloiwa R, Wolter N, Mupere E, Tan T, Chitkara AJ, Forsyth KD, von Konig CW, Hussey G (2018) Pertussis in Africa: findings and recommendations of the Global Pertussis Initiative (GPI). Vaccine 36(18):2385–2393. https://doi.org/10.1016/j.vaccine.2018.03.025
Nunes MC, Soofie N, Downs S, Tebeila N, Mudau A, de Gouveia L, Madhi SA (2016) Comparing the yield of nasopharyngeal swabs, nasal aspirates, and induced sputum for detection of Bordetella pertussis in hospitalized infants. Clin Infect Dis 63(suppl 4):S181–S186. https://doi.org/10.1093/cid/ciw521
Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, Cerdeno-Tarraga AM, Temple L, James K, Harris B, Quail MA, Achtman M, Atkin R, Baker S, Basham D, Bason N, Cherevach I, Chillingworth T, Collins M, Cronin A, Davis P, Doggett J, Feltwell T, Goble A, Hamlin N, Hauser H, Holroyd S, Jagels K, Leather S, Moule S, Norberczak H, O’Neil S, Ormond D, Price C, Rabbinowitsch E, Rutter S, Sanders M, Saunders D, Seeger K, Sharp S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Unwin L, Whitehead S, Barrell BG, Maskell DJ (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35(1):32–40. https://doi.org/10.1038/ng1227
Plotkin SA (2013) Complex correlates of protection after vaccination. Clin Infect Dis 56(10):1458–1465. https://doi.org/10.1093/cid/cit048
Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S (2018) Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW public health network case-control study. Vaccine 36(14):1887–1892. https://doi.org/10.1016/j.vaccine.2018.02.047
Scott S, van der Sande M, Faye-Joof T, Mendy M, Sanneh B, Barry Jallow F, de Melker H, van der Klis F, van Gageldonk P, Mooi F, Kampmann B (2015) Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J 34(4):333–338. https://doi.org/10.1097/INF.0000000000000576
Sebaihia M, Preston A, Maskell DJ, Kuzmiak H, Connell TD, King ND, Orndorff PE, Miyamoto DM, Thomson NR, Harris D, Goble A, Lord A, Murphy L, Quail MA, Rutter S, Squares R, Squares S, Woodward J, Parkhill J, Temple LM (2006) Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B-bronchiseptica, B-pertussis, and B-parapertussis reveals extensive diversity in surface structures associated with host interaction. J Bacteriol 188(16):6002–6015. https://doi.org/10.1128/Jb.01927-05
Sobanjo-Ter Meulen A, Duclos P, McIntyre P, Lewis KD, Van Damme P, O’Brien KL, Klugman KP (2016) Assessing the evidence for maternal pertussis immunization: a report from the Bill & Melinda Gates Foundation Symposium on pertussis infant disease burden in low- and lower-middle-income countries. Clin Infect Dis 63(suppl 4):S123–S133. https://doi.org/10.1093/cid/ciw530
Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh PR, Lu CY, Balaji V, Moriuchi H, Nakashima Y, Lu M, Yang Y, Yao K, Kim SH, Song JH, Kim S, Kim MJ, Heininger U, Chiu CH, Kim YJ (2019) Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. Clin Microbiol Infect 25(2):250 e251–250 e257. https://doi.org/10.1016/j.cmi.2018.04.013
Sweden PHAo (2018) Pertussis surveillance in Sweden. Nineteen-year report. Available at https://www.folkhalsomyndigheten.se/contentassets/65ed8f6dbdab4999bc358fcd9b657e77/pertussis-sweden-nineteen-year-report.pdf. Accessed on Feb 2019
Turner HC, Thwaites GE, Clapham HE (2018) Vaccine-preventable diseases in lower-middle-income countries. Lancet Infect Dis 18(9):937–939. https://doi.org/10.1016/S1473-3099(18)30478-X
von Koenig CHW, Guiso N (2017) Global burden of pertussis: signs of hope but need for accurate data. Lancet Infect Dis 17(9):889–890. https://doi.org/10.1016/S1473-3099(17)30357-2
Wang Z, Cui Z, Li Y, Hou T, Liu X, Xi Y, Liu Y, Li H, He Q (2014) High prevalence of erythromycin-resistant Bordetella pertussis in Xi’an, China. Clin Microbiol Infect 20(11):O825–O830. https://doi.org/10.1111/1469-0691.12671
WHO (2014a) Laboratory Manual for the diagnosis of whooping cough caused by bordetella pertussis/bordetella parapertussis: update 2014. Available at http://www.who.int/iris/handle/10665/127891. Accessed on Feb 2019
WHO (2014b) Report from the SAGE working group on pertussis vaccines, 26–27 august 2014 meeting, Geneva. Available at https://www.who.int/immunization/sage/meetings/2015/april/1_Pertussis_report_final.pdf?ua=1. Accessed on Feb 2019
WHO (2014c) WHO expert committee on biological standardization. sixty-third report. Recommendations to assure the quality, safety and efficacy of DT-based combined vaccines Available at https://www.who.int/biologicals/vaccines/Combined_Vaccines_TRS_980_Annex_6.pdf?ua=1. Accessed on Feb 2019
WHO (2015) Pertussis vaccines: WHO position paper. Available at https://www.who.int/wer/2015/wer9035.pdf. Accessed on Feb 2019
WHO (2017) The immunological basis for immunization series: module 4: pertussis, update 2017. Available at https://apps.who.int/iris/bitstream/handle/10665/259388/9789241513173-eng.pdf?sequence=1&isAllowed=y. Accessed on Feb 2019
Yao N, Zeng Q, Wang Q (2018) Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection. Public Health 156:60–66. https://doi.org/10.1016/j.puhe.2017.12.009
Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW (2017) An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis 17(9):974–980. https://doi.org/10.1016/S1473-3099(17)30390-0
Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11(7):557–570. https://doi.org/10.1016/S1473-3099(11)70007-X
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Guiso, N., Taieb, F. (2019). Pertussis in Low and Medium Income Countries: A Pragmatic Approach. In: Fedele, G., Ausiello, C. (eds) Pertussis Infection and Vaccines. Advances in Experimental Medicine and Biology(), vol 1183. Springer, Cham. https://doi.org/10.1007/5584_2019_409
Download citation
DOI: https://doi.org/10.1007/5584_2019_409
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33248-8
Online ISBN: 978-3-030-33249-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)